This is highlighted in Dravet syndrome (DS), a treatment-resistant form of epilepsy with a high risk for SUDEP, where loss-of-function mutations have been reported in the SCN1A gene, which encodes a subtype of voltage-gated sodium channel in the brain. Here, SCN1A is linked to epilepsy.